The role of existing and novel cardiac biomarkers for cardioprotection.

  • David C. Gaze
  • Published 2007 in Current opinion in investigational drugs

Abstract

Cardioprotection is an all-encompassing term for physico-biochemical or therapeutic interventions which slow or ameliorate the progression of cardiomyocyte necrosis. There are a number of established and novel biomarkers to assess coronary artery disease at initiation, ischemia, necrosis and myocardial dysfunction. Established biomarkers such as creatine… (More)

Topics

Cite this paper

@article{Gaze2007TheRO, title={The role of existing and novel cardiac biomarkers for cardioprotection.}, author={David C. Gaze}, journal={Current opinion in investigational drugs}, year={2007}, volume={8 9}, pages={711-7} }